Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Blood Pressure Lowering in Type 2 Diabetes

    JAMA: The Journal of the American Medical Association Date published:

  • The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study

    BMJ Date published:

  • Co-payments for health care: what is their real cost?

    Australian Health Review Date published:

  • Assessing the Validity of Surrogate Outcomes for ESRD: A Meta-Analysis

    Journal of the American Society of Nephrology Date published:

  • Fibrates: Risk Benefits and Role in Treating Dyslipidemias

    Dyslipidemias Date published:

  • Association between Serum Alkaline Phosphatase and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial

    Canadian Journal of Kidney Health and Disease Date published:

  • A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial

    American Journal of Kidney Diseases Date published:

  • Clinical characteristics of IgA nephropathy associated with low complement 4 levels

    Renal Failure Date published:

  • Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes

    Diabetes Care Date published:

  • Interventions for preventing intradialytic hypotension in haemodialysis patients

    Cochrane Database of Systematic Reviews Date published:

  • Optimal targets for blood pressure control in chronic kidney disease

    Current Opinion in Nephrology & Hypertension Date published:

  • Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes

    New England Journal of Medicine Date published:

  • The modifiable burden of worldwide mortality from cardiovascular diseases

    The Lancet Diabetes & Endocrinology Date published:

  • The modifiable burden of worldwide mortality from cardiovascular diseases

    The Lancet Diabetes & Endocrinology Date published:

  • Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

    The Lancet Date published:

  • Effect of Hemodiafiltration or Hemofiltration Compared With Hemodialysis on Mortality and Cardiovascular Disease in Chronic Kidney Failure: A Systematic Review and Meta-analysis of Randomized Trials

    American Journal of Kidney Diseases Date published: